Skip to search formSkip to main contentSkip to account menu

CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine

Known as: CTX/DOX/PRED/VCR, ACOP, cyclophosphamide, doxorubicin, prednisone, and vincristine protocol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Background: Rituximab (R) plus CHOP (R-CHOP) is standard-of-care treatment for previously untreated diffuse large B-cell lymphoma… 
2009
2009
Bortezomib demonstrated promising activity in lymphomas. The authors conducted a randomized phase 2 trial of frontline rituximab… 
2009
2009
There is no data about the efficacy and safety of radioimmunotherapy with 90Y‐ibritumomab tiuxetan in patients with relapsed or… 
2008
2008
AbstractBackground The addition of rituximab to doxorubicin-containing standard chemotherapy significantly improves response to… 
Highly Cited
2007
Highly Cited
2007
Purpose: To evaluate 3′-deoxy-3′-[18F]fluorothymidine-positron emission tomography (FLT-PET) for early monitoring response of… 
2007
2007
To study domain organization and movements in the reaction cycle of heavy metal ion pumps, CopA, a bacterial Cu+-ATPase from… 
Highly Cited
2003
Highly Cited
2003
In this paper the interaction of cytoplasmic CopZ and the N-terminal domain of the CopA ATPase from Bacillus subtilis has been… 
2001
2001
To determine role of highly active antiretroviral therapy (HAART) and additional factors in incidence and outcome of patients… 
2001
2001
We describe a case of relapsed intravascular lymphomatosis (IVL) successfully treated with autologous PBSCT. A 59-year-old… 
Highly Cited
1995
Highly Cited
1995
A prospective randomized clinical trial with simultaneous data collection for an economic appraisal was carried out to assess the…